Webinar: Pigmentation: Disorders, Causes, and Treatments

Pigmentation: Disorders, Causes, and Treatments

Hyperpigmentation is a complicated condition faced by many skin care professionals and consumers alike. This presentation will explore the mechanisms of melanin formation and melanocyte function, as well as associated states of hypo and hyperpigmentation. Learn why the enzymes tyrosinase, phenylalanine oxidase, and newly discovered lightening mechanisms such as melanosome transfer (MIT) and melanin stimulating hormones (MSH) inhibitors are key components in melanin formation.


Michael Q. Pugliese, BS, LE is an informed educator, writer, and asset to the skin care industry and the third-generation CEO of Circadia by Dr. Pugliese in 2006. His dedication and leadership to the brand has grown to achieve international recognition and distribution worldwide. This global expansion has created a skin care regimen for every skin type in the world. Pugliese’s compelling lectures honors the tenets of modern skin science discovered originally by his grandfather.  By following in his grandfather’s footsteps, he has been driven to deliver a clear message on skin care to all his clients and fellow educators in the industry. In addition to the success in the skin care line, Circadia also has the first physician formulated pillowcase. This is formulated to work in harmony with the body’s natural circadian rhythms which protect from environmental damage, while focusing on skin repair during evenings rest.




Want to read more?

Log in or subscribe to continue reading this article.


Pigmentation: Disorders, Causes, and Treatments
Login to post comments

State Board Requirements

FAQs with AIA

Events Calendar